Clinical Trials in the EU: Voluntary Harmonisation Procedure

This webcast will give you the latest information on the VHP in the EU. You will learn about the application procedure, benefits and risks, content and format of the submission of CTAs. The information will help you to build the right regulatory strategy for your clinical trial application in the EU. The company will benefit from access to three countries with one application.